An observational study in Cerebral Vasospasm and Aneurysmal Subarachnoid Hemorrhage (aSAH), sponsored by Vesalio. Recruiting at 16 sites in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Vesalio · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Vasospasm, Intracranial with a site in United States — 6 open to participants now, 7 under way, none of them phase 3. Vasospasm, Intracranial · United States.
Among the 37 studies in Vasospasm, Intracranial with a site in United States, this one is the only one that started in 2025, is one of 9 observational ones, and was the 34th registered.
82 studies on the registry are indexed under Vasospasm, Intracranial; 15 are open to participants now.
Browse Vasospasm, Intracranial studies →6 of the 37 studies in Vasospasm, Intracranial with a site in United States are open now. Recruiting first, the newest first:
Marshall Holland · Sites in United States
Ages 18–65
Massachusetts General Hospital · Sites in United States, Italy
Ages 18+ · Healthy volunteers
University of California, San Diego · Sites in United States
Ages 18–110
Stanford University · Sites in United States
Ages 18+
University of Texas Southwestern Medical Center · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 11 Vasospasm, Intracranial studies recruiting now, 5 (45%) set no upper age limit and 2 (18%) stop at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: 22 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 11 · Phase 3 2 · Phase 4 3
First in 2005; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 60 across 24 observational studies indexed under Vasospasm, Intracranial.
Median enrollment 25 across the 28 interventional studies, 40 across the 9 observational. Of the 23 that completed or were terminated, 12 (52%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 37 have an industry lead sponsor. The 10 most frequent:
Vesalio is the lead sponsor of 9 studies on the registry; 2 are open to participants now.
Vesalio has 2 studies filed under Vasospasm, Intracranial — fewer than ten, so there is no comparison to draw.
4 of the studies in Vasospasm, Intracranial with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05230134Stanford UniversityCervical Sympathetic Block in Patients With Cerebral Vasospasm | 2026-12 |
| NCT03065231University of California, San DiegoLumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage | 2027-01-04 |
| NCT06893588VesalioRegistry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts | 2027-02-14 |
| NCT07614906Massachusetts General HospitalNitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage | 2027-05 |
Add all 4 to your calendar (.ics) → With an account.
Among the 37 studies in Vasospasm, Intracranial with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
subjects with cerebral vasospasm
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: NEVA VS
cerebral artery dilation device
Improvement in target vessel diameter following NeVa VS use
Time frame: Up to 1 hour post procedure
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2025 (actual). Primary completion is estimated for Feb 2027, 22 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vesalio